Evidence-based management of lipid disorders / / Maud N. Vissers, John J.P. Kastelein, Erik S. Stroes, [editors]

• Record Nr.: UNINA9910789125703321
• Autore: Vissers Maud N
• Pubbl/distr/stampa: Harley : , : TFM, , 2010
• ISBN: 1-908986-59-X
• Descrizione fisica: 1 online resource (322 p.)
• Altri autori (Persone): VissersMaud N; KasteleinJohn J. P; StroesErik S
• Disciplina: 616.399706
• Soggetti: Lipids - Metabolism - Disorders - Treatment; Evidence-based medicine
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references and index.
• Nota di contenuto: ""COVER FRONT""; ""Contents""; ""Foreword""; ""Contributors""; ""Acknowledgements""; ""Using evidence-based medicine""; ""Chapter 1 How much evidence is enough?""; ""Chapter 2 A brief review of lipoprotein metabolism""; ""Chapter 3 Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases""; ""Chapter 4 Are LDL cholesterol-lowering functional food ingredients successful in the long term?""; ""Chapter 5 Evidence-based treatment of primary hypo- and hypercholesterolemic disorders""; ""Chapter 6 Does raising HDL protect against atherosclerosis?""; ""Chapter 7 How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment?""""Chapter 8 The optimal treatment of patients with familial combined hyperlipidemia""; ""Chapter 9 How to manage lipid and lipoprotein disorders in children""; ""Chapter 10 Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus""; ""Chapter 11 What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels?""; ""Chapter 12 The link between chronic inflammatory diseases and cardiovascular risk""""Chapter 13 What is the evidence for a physiological and pathogenic role of lipoprotein (a)?""; ""Chapter 14 ; Sitosterolemia; xenophobia for the body""; ""Chapter 15 How can we deal with inborn errors in cholesterol and bile acid biosynthesis?""; ""Chapter 16 Differential diagnosis of patients with xanthomas and xanthelasmata""; ""Chapter 17 When should we fear statin interactions?""; ""Chapter 18 What are the considerations in patients who are statin â€?intolerantâ€??""; ""Index""; ""COVER BACK""